Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President Trump's ...
The decision hinges on balancing higher upfront costs and regulatory challenges against long-term efficiency gains and scalability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results